Balyasny Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-34,433
| Closed | -$82.6K | – | 2221 |
|
|
2024
Q1 | $82.6K | Buy |
+34,433
| New | +$82.6K | ﹤0.01% | 1885 |
|
|
2023
Q1 | – | Sell |
-38,377
| Closed | -$73.3K | – | 2456 |
|
|
2022
Q4 | $73.3K | Buy |
+38,377
| New | +$73.3K | ﹤0.01% | 1851 |
|
|
2022
Q3 | – | Sell |
-16,363
| Closed | -$30K | – | 2587 |
|
|
2022
Q2 | $30K | Buy |
+16,363
| New | +$30K | ﹤0.01% | 1975 |
|
|
2018
Q4 | – | Sell |
-103,741
| Closed | -$1.11M | – | 1445 |
|
|
2018
Q3 | $1.11M | Buy |
+103,741
| New | +$1.11M | 0.01% | 941 |
|
|
2017
Q2 | – | Sell |
-731,985
| Closed | -$10.5M | – | 1391 |
|
|
2017
Q1 | $10.5M | Buy |
731,985
+13,480
| +2% | +$193K | 0.05% | 415 |
|
|
2016
Q4 | $9.94M | Buy |
718,505
+166,605
| +30% | +$2.3M | 0.05% | 393 |
|
|
2016
Q3 | $9.97M | Buy |
551,900
+370,786
| +205% | +$6.7M | 0.06% | 379 |
|
|
2016
Q2 | $2.6M | Buy |
181,114
+49,070
| +37% | +$704K | 0.02% | 502 |
|
|
2016
Q1 | $1.58M | Buy |
+132,044
| New | +$1.58M | 0.01% | 540 |
|
|
2015
Q4 | – | Sell |
-600,951
| Closed | -$6.45M | – | 1201 |
|
|
2015
Q3 | $6.45M | Buy |
+600,951
| New | +$6.45M | 0.05% | 388 |
|